Dose-dependent reversal of KCC2 hypofunction and phenobarbital-resistant neonatal seizures by ANA12

B M Carter1, B J Sullivan1, J R Landers1

  • 1Neuroscience Laboratory, Hugo Moser Research Institute at Kennedy Krieger, Baltimore, MD, USA.

Scientific Reports
|August 12, 2018
PubMed

Insights

ANA12, a TrkB antagonist, effectively treated phenobarbital-resistant neonatal seizures in mice by restoring KCC2 function. This offers a promising therapeutic strategy for refractory seizures in newborns.

Area of Science:

  • Neuroscience
  • Neonatal Neurology
  • Pharmacology

Background:

  • Neonatal seizures affect 3.5 per 1000 newborns, with hypoxic-ischemic encephalopathy (HIE) being a major cause.
  • Half of HIE cases are resistant to first-line anti-seizure drugs like phenobarbital (PB).
  • Tyrosine receptor kinase B (TrkB) activation post-ischemia increases neuronal excitability by downregulating K-Cl co-transporter 2 (KCC2).

Purpose of the Study:

  • To evaluate the anti-seizure efficacy of ANA12, a selective TrkB antagonist, in neonatal ischemia models.
  • To investigate ANA12's effects on KCC2 function and TrkB pathway activation following ischemia.
  • To determine if ANA12 can rescue phenobarbital-resistant neonatal seizures.

Main Methods:

  • Three doses of ANA12 were administered to CD1 mice at postnatal days 7 and 10 after inducing neonatal ischemia.
  • Phenobarbital (PB) loading dose was kept constant across all groups.
  • Efficacy was assessed via electroencephalography (EEG) seizure burden, KCC2/pKCC2-S940 levels, and TrkB pathway activation.

Main Results:

  • ANA12 dose-dependently rescued PB-resistant seizures at P7 and improved PB efficacy at P10.
  • ANA12 reversed post-ischemic KCC2 downregulation and TrkB pathway activation at P7, where PB was ineffective alone.
  • Female pups showed a better response to lower ANA12 doses compared to males.

Conclusions:

  • ANA12 demonstrates significant anti-seizure efficacy in neonatal ischemia, particularly for PB-resistant cases.
  • Restoring KCC2 hypofunction via TrkB antagonism is a critical mechanism for preventing refractory neonatal seizures.
  • ANA12 presents a potential therapeutic avenue for managing challenging neonatal seizure conditions.

Related Concept Videos

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
689
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.6K
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
310
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
246
Frequency-dependent Selection01:21

Frequency-dependent Selection

When the fitness of a trait is influenced by how common it is (i.e., its frequency) relative to different traits within a population, this is referred to as frequency-dependent selection. Frequency-dependent selection may occur between species or within a single species. This type of selection can either be positive—with more common phenotypes having higher fitness—or negative, with rarer phenotypes conferring increased fitness.
24.1K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K